One type of immunotherapy removes a genetic blindfold that cancer uses to hide from the immune system. These “PD-1 inhibitors,” including drugs like pembrolizumab, nivolumab and atezolizum...
A diagnosis of the brain cancer glioblastoma carries a dismal prognosis, with most patients dying within five years. Now a team led by Massachusetts General Hospital (MGH) investigators has found that...